Ушбу иш иқтибос қилган ишлар

292 та иш

Иш: Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao +4
Шарҳ мақола20247 иқтибос
ABI
The Evolving Future of PCSK9 Inhibitors
Robert S. Rosenson, Robert A. Hegele, Sergio Fazio +1
Шарҳ мақола20184 иқтибос
ABI
Spotlight on therapeutic efficiency of green synthesis metals and their oxide nanoparticles in periodontitis
Mohammad Kiarashi, Parham Mahamed, Nader Ghotbi +6
Мақола20243 иқтибос
ABI
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg, Chung-Chou H. Chang, Lewis H. Kuller +25
Мақола20133 иқтибос
ABI
Current hurdles to the translation of nanomedicines from bench to the clinic
Snežana Đorđević, María Medel Gonzalez, Inmaculada Conejos‐Sánchez +6
Шарҳ мақола20213 иқтибос
ABI
Recent advances in metal nanoparticles to treat periodontitis
Kamyar Nasiri, Seyed Mohammad Reza Masoumi, Sara Amini +7
Шарҳ мақола20233 иқтибос
ABI
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
Elham Oveili, Somayeh Vafaei, Haniyeh Bazavar +4
Шарҳ мақола20233 иқтибос
ABI
Mesenchymal Stem Cell-based Scaffolds in Regenerative Medicine of Dental Diseases
Mohammad Kiarashi, Hannaneh Bayat, Seyed Abbas Shahrtash +6
Шарҳ мақола20243 иқтибос
ABI
A Common PCSK9Haplotype, Encompassing the E670G Coding Single Nucleotide Polymorphism, Is a Novel Genetic Marker for Plasma Low-Density Lipoprotein Cholesterol Levels and Severity of Coronary Atherosclerosis
Suet N. Chen, Christie M. Ballantyne, Antonio M. Gotto +3
Мақола20053 иқтибос
ABI
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh +10
Шарҳ мақола20223 иқтибос
ABI
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya +17
Мақола20132 иқтибос
ABI
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
Nicolas Bertrand, P. Grenier, Morteza Mahmoudi +7
Мақола20172 иқтибос
ABI
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing
Reindert F. Oostveen, Amit V. Khera, Sekar Kathiresan +5
Шарҳ мақола20232 иқтибос
ABI
Lipid-based nanoparticle formulations for small molecules and RNA drugs
Ludger M. Ickenstein, Patrick Garidel
Шарҳ мақола20192 иқтибос
ABI
Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
Rainer Schulz, Klaus‐Dieter Schlüter, Ulrich Laufs
Шарҳ мақола20152 иқтибос
ABI
PCSK9 and LDLR degradation
Thomas A. Lagace
Шарҳ мақола20142 иқтибос
ABI
PCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci, Massimiliano Ruscica, Marina Camera +10
Мақола20182 иқтибос
ABI
PCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi‐Borojeni, Sarvenaz Sabouri-Rad, Antonio M. Gotto +5
Шарҳ мақола20192 иқтибос
ABI
Proprotein Convertase Subtilisin/Kexin Type 9
Chiara Macchi, Nicola Ferri, Cesare R. Sirtori +3
Шарҳ мақола20212 иқтибос
ABI
PCSK9-targeted therapies: present and future approaches
Mahmoud Al Rifai, Christie M. Ballantyne
Шарҳ мақола20212 иқтибос
ABI
May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
Roberto Scicali, Antonino Di Pino, Salvatore Piro +2
Шарҳ мақола20202 иқтибос
ABI
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Fotios Barkas, Haralampos Milionis, Georgia Anastasiou +1
Шарҳ мақола20202 иқтибос
ABI
PCSK9
Nabil G. Seidah, Zuhier Awan, Michel Chrétien +1
Шарҳ мақола20142 иқтибос
ABI
Adverse Events Associated With <scp>PCSK</scp>9 Inhibitors: A Real‐World Experience
Muhammed T. Gürgöze, A H G Muller-Hansma, Michelle M. Schreuder +3
Мақола20182 иқтибос
ABI
A multi-target therapeutic potential of Prunus domestica gum stabilized nanoparticles exhibited prospective anticancer, antibacterial, urease-inhibition, anti-inflammatory and analgesic properties.
Nazar Ul Islam, Raza Amin, Muhammad Shahid +3
Мақола20172 иқтибос
ABI